Serglycin participates in retention of α-defensin in granules during myelopoiesis

Blood

Volumn 118, Issue 16, 2011, Pages 4440-4448

  Glenthøj, Andreas ^a   Cowland, Jack B ^a   Heegaard, Niels H ^b   Larsen, Maria T ^a   Borregaard, Niels ^a  

^a Rigshospitalet   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; LEUKOCYTE ELASTASE; PLASMA PROTEIN; PLASMA PROTEIN HNP1; PROTEOGLYCAN; SERGLYCIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL SELECTION; CONTROLLED STUDY; GENETIC TRANSFECTION; GRANULOCYTE PRECURSOR; HUMAN; HUMAN CELL; MOUSE; MYELOPOIESIS; NEUTROPHIL GRANULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; WESTERN BLOTTING;

EID: 80054842512     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-06-362947     Document Type: Article

References (46)

1. Lemansky P, Gerecitano-Schmidek M, Das RC, Schmidt B, Hasilik A. Targeting myeloperoxidase to azurophilic granules in HL-60 cells. J Leukoc Biol. 2003;74(4):542-550. (Pubitemid 38040381)
2. Kolset SO, Prydz K, Pejler G. Intracellular proteoglycans. Biochem J. 2004;379(Pt 2):217-227. (Pubitemid 38570093)
3. Kolset SO, Gallagher JT. Proteoglycans in haemopoietic cells. Biochim Biophys Acta. 1990; 1032(2-3):191-211. (Pubitemid 120036338)
4. Serafin WE, Katz HR, Austen KF, Stevens RL. Complexes of heparin proteoglycans, chondroitin sulfate E proteoglycans, and [3H]diisopropyl fluorophosphate-binding proteins are exocytosed from activated mouse bone marrow-derived mast cells. J Biol Chem. 1986;261(32):15017-15021. (Pubitemid 17218067)
5. Niemann CU, Cowland JB, Klausen P, Askaa J, Calafat J, Borregaard N. Localization of serglycin in human neutrophil granulocytes and their precursors. J Leukoc Biol. 2004;76(2):406-415. (Pubitemid 39006955)
6. Niemann CU, Abrink M, Pejler G, et al. Neutrophil elastase depends on serglycin proteoglycan for localization in granules. Blood. 2007;109(10): 4478-4486. (Pubitemid 46743418)
7. Lemansky P, Smolenova E, Wrocklage C, Hasilik A. Neutrophil elastase is associated with serglycin on its way to lysosomes in U937 cells. Cell Immunol. 2007;246(1):1-7. (Pubitemid 47087771)
8. Ganz T, Selsted ME, Lehrer RI. Defensins. Eur J Haematol. 1990;44(1):1-8. (Pubitemid 20118414)
9. Valore EV, Martin E, Harwig SS, Ganz T. Intramolecular inhibition of human defensin HNP-1 by its propiece. J Clin Invest. 1996;97(7):1624-1629. (Pubitemid 26105473)
10. Valore EV, Ganz T. Posttranslational processing of defensins in immature human myeloid cells. Blood. 1992;79(6):1538-1544.
11. Wilson CL, Ouellette AJ, Satchell DP, et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science. 1999;286(5437):113-117. (Pubitemid 29484488)
12. Ghosh D, Porter E, Shen B, et al. Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol. 2002;3(6):583-590. (Pubitemid 34662312)
13. Kamdar K, Maemoto A, Qu X, Young SK, Ouellette AJ. In vitro activation of the rhesus macaque myeloid alpha-defensin precursor proRMAD-4 by neutrophil serine proteinases. J Biol Chem. 2008;283(47):32361-32368.
14. Arnljots K, Sorensen O, Lollike K, Borregaard N. Timing, targeting and sorting of azurophil granule proteins in human myeloid cells. Leukemia. 1998; 12(11):1789-1795. (Pubitemid 28502499)
15. Faurschou M, Sorensen OE, Johnsen AH, Askaa J, Borregaard N. Defensin-rich granules of human neutrophils: characterization of secretory properties. Biochim Biophys Acta. 2002;1591(1-3):29-35. (Pubitemid 35232065)
16. Faurschou M, Kamp S, Cowland JB, et al. Prodefensins are matrix proteins of specific granules in human neutrophils. J Leukoc Biol. 2005;78(3): 785-793. (Pubitemid 41292102)
17. Eisenhauer PB, Lehrer RI. Mouse neutrophils lack defensins. Infect Immun. 1992;60(8):3446-3447.
18. Ganz T, Liu L, Valore EV, Oren A. Posttranslational processing and targeting of transgenic human defensin in murine granulocyte, macrophage, fibroblast, and pituitary adenoma cell lines. Blood. 1993;82(2):641-650. (Pubitemid 23206133)
19. Rorvig S, Honore C, Larsson LI, et al. Ficolin-1 is present in a highly mobilizable subset of human neutrophil granules and associates with the cell surface after stimulation with fMLP. J Leukoc Biol. 2009;86(6):1439-1449.
20. Sorensen OE, Follin P, Johnsen AH, et al. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood. 2001;97(12): 3951-3959.
21. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(5259):680-685.
22. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979;76(9): 4350-4354. (Pubitemid 9256559)
23. Borregaard N, Sehested M, Nielsen BS, Sengelov H, Kjeldsen L. Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil differentiation. Blood. 1995;85(3):812-817.
24. Schagger H. Tricine-SDS-PAGE. Nat Protoc. 2006;1(1):16-22.
25. Jacobsen LC, Sorensen OE, Cowland JB, Borregaard N, Theilgaard-Monch K. The secretory leukocyte protease inhibitor (SLPI) and the secondary granule protein lactoferrin are synthesized in myelocytes, colocalize in subcellular fractions of neutrophils, and are coreleased by activated neutrophils. J Leukoc Biol. 2008;83(5): 1155-1164. (Pubitemid 351960347)
26. Clemmensen SN, Jacobsen LC, Rorvig S, et al. Alpha-1-antitrypsin is produced by human neutrophil granulocytes and their precursors and liberated during granule exocytosis. Eur J Haematol. 2011;86(6):517-530.
27. Abrink M, Grujic M, Pejler G. Serglycin is essential for maturation of mast cell secretory granule. J Biol Chem. 2004;279(39):40897-40905. (Pubitemid 39287689)
28. Bdeir K, Higazi AA, Kulikovskaya I, et al. Neutrophil alpha-defensins cause lung injury by disrupting the capillary-epithelial barrier. Am J Respir Crit Care Med. 2010;181(9):935-946.
29. Tkalcevic J, Novelli M, Phylactides M, Iredale JP, Segal AW, Roes J. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity. 2000;12(2):201-210. (Pubitemid 30398634)
30. Gobom J, Schuerenberg M, Mueller M, Theiss D, Lehrach H, Nordhoff E. Alpha-cyano-4-hydroxycinnamic acid affinity sample preparation. A protocol for MALDI-MS peptide analysis in proteomics. Anal Chem. 2001;73(3):434-438.
31. Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silverstained polyacrylamide gels. Anal Chem. 1996; 68(5):850-858.
32. Drexler HG, Dirks WG, Matsuo Y, MacLeod RA. False leukemia-lymphoma cell lines: an update on over 500 cell lines. Leukemia. 2003;17(2):416- 426.
33. Pejler G, Abrink M, Wernersson S. Serglycin proteoglycan: regulating the storage and activities of hematopoietic proteases. Biofactors. 2009;35(1): 61-68.
34. Metkar SS, Wang B, Aguilar-Santelises M, et al. Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation. Immunity. 2002;16(3):417-428. (Pubitemid 34260919)
35. Schick BP, Gradowski JF, San Antonio JD. Synthesis, secretion, and subcellular localization of serglycin proteoglycan in human endothelial cells. Blood. 2001;97(2):449-458. (Pubitemid 32060330)
36. Tantravahi RV, Stevens RL, Austen KF, Weis JH. A single gene in mast cells encodes the core peptides of heparin and chondroitin sulfate proteoglycans. Proc Natl Acad Sci U S A. 1986;83(23): 9207-9210. (Pubitemid 17223564)
37. Woulfe DS, Lilliendahl JK, August S, et al. Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice. Blood. 2008;111(7):3458-3467.
38. Braga T, Ringvall M, Tveit H, Abrink M, Pejler G. Reduction with dithiothreitol causes serglycin-specific defects in secretory granule integrity of bone marrow derived mast cells. Mol Immunol. 2009;46(3):422-428.
39. Grujic M, Braga T, Lukinius A, et al. Serglycin-deficient cytotoxic T lymphocytes display defective secretory granule maturation and granzyme B storage. J Biol Chem. 2005;280(39):33411-33418. (Pubitemid 41397139)
40. Grujic M, Christensen JP, Sorensen MR, Abrink M, Pejler G, Thomsen AR. Delayed contraction of the CD8+ T cell response toward lymphocytic choriomeningitis virus infection in mice lacking serglycin. J Immunol. 2008;181(2):1043-1051.
41. Higazi AA, Nassar T, Ganz T, et al. The alpha-defensins stimulate proteoglycan-dependent catabolism of low-density lipoprotein by vascular cells: a new class of inflammatory apolipoprotein and a possible contributor to atherogenesis. Blood. 2000;96(4):1393-1398. (Pubitemid 30658469)
42. Lichtenstein A. Mechanism of mammalian cell lysis mediated by peptide defensins. Evidence for an initial alteration of the plasma membrane. J Clin Invest. 1991;88(1):93-100.
43. Lichtenstein A, Ganz T, Selsted ME, Lehrer RI. In vitro tumor cell cytolysis mediated by peptide defensins of human and rabbit granulocytes. Blood. 1986;68(6):1407-1410. (Pubitemid 17228824)
44. Lichtenstein AK, Ganz T, Nguyen TM, Selsted ME, Lehrer RI. Mechanism of target cytolysis by peptide defensins. Target cell metabolic activities, possibly involving endocytosis, are crucial for expression of cytotoxicity. J Immunol. 1988;140(8): 2686-2694.
45. Higazi AA, Lavi E, Bdeir K, et al. Defensin stimulates the binding of lipoprotein (a) to human vascular endothelial and smooth muscle cells. Blood. 1997;89(12):4290-4298. (Pubitemid 27260236)
46. Bdeir K, Cane W, Canziani G, et al. Defensin promotes the binding of lipoprotein(a) to vascular matrix. Blood. 1999;94(6):2007-2019. (Pubitemid 29430417)